SCHEMBL6207150

SCHEMBL6207150

CC1(Cc2ccncc2NS(=O)(=O)c2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 3/20 0.44
SLC40A1 Q9NP59 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
NAMPT P43490 2/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
EPHX2 P34913 1/20 0.34
PTGS2 P35354 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6224943 0.92 CCR9 (0.46) CCR9NAMPTMAPTKMT2ACYP2C9
SCHEMBL6177182 0.89 ALDH1A1 (0.36) CCR9SMN1; SMN2NAMPTALDH1A1TP53
SCHEMBL6173837 0.89 LIPE (0.38) CCR9ALDH1A1KDM4ECYP3A4GAA
SCHEMBL6173098 0.88 FLT1 (0.36) CCR9NAMPTALDH1A1KDM4ELMNA
SCHEMBL6175495 0.87 CYP3A4 (0.36) CCR9NAMPTMAPTALDH1A1KMT2A
SCHEMBL6173018 0.87 CCR9 (0.37) CCR9SMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL6176637 0.87 IGF1R (0.40) SMN1; SMN2ALDH1A1KDM4ELMNATP53
SCHEMBL6173183 0.85 CYP3A4 (0.39) CCR9ALDH1A1CYP3A4GAACYP2C9
SCHEMBL6173294 0.84 CYP3A4 (0.38) CCR9ALDH1A1CYP3A4GAACYP2C9
SCHEMBL6176657 0.83 CYP3A4 (0.40) NAMPTALDH1A1CYP3A4GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed